2024-03-14 14:49:13 ET
ImmunoPrecise Antibodies Ltd. (IPA)
Q3 2024 Earnings Conference Call
March 14, 2024 10:30 AM ET
Company Participants
Jennifer Bath - Chief Executive Officer and President
Kristin Taylor - Chief Financial Officer
Conference Call Participants
Will McHale - Ingalls and Snyder
Swayampakula Ramakanth - H.C. Wainright
Presentation
Operator
Good morning, ladies and gentlemen. Thank you for joining us today for IPA's Earnings covering the Third Quarter of Fiscal Year 2024. I am Mandip, and I have the privilege of hosting this call.
Before we commence, I would like to draw your attention to the fact that our discussions today may include forward-looking statements. These statements are subject to various risks and uncertainties that could cause actual results to differ materially from what we expressed or implied. We strongly encourage you to review our filings with the Securities and Exchange Commission for a comprehensive discussion of these risks and uncertainties. IPA remains committed to complying with legal requirements and will update forward-looking statements only as mandated by law....
Read the full article on Seeking Alpha
For further details see:
ImmunoPrecise Antibodies Ltd. (IPA) Q3 2024 Earnings Call Transcript